Indeed, bioinformatic analysis revealed that DNMT3A and DNMT3B are miR-29btargets, according with previous studies which reported the ability of members of the miR-29-familyto target DNMTs in solid tumors and AML [24, 38]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.